Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Correlation between lipophilicity and triptan outcomes.

Julio Pascual1, Pedro Muñoz

  • 1University Hospital M de Valdecilla, 39008 Santander, Spain.

Headache
|January 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish setting.

Nefrologia·2026
Same author

Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parameters.

Cephalalgia : an international journal of headache·2026
Same author

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Cephalalgia : an international journal of headache·2026
Same author

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Neurology·2026
Same author

Steroid avoidance or withdrawal for kidney transplant recipients.

The Cochrane database of systematic reviews·2026
Same author

Correction: Switching strategies with CGRP monoclonal antibodies: an observational study in a headache clinic.

Frontiers in neurology·2026

Higher lipophilicity in triptans does not improve efficacy but may increase central nervous system (CNS) adverse events (AE) and potentially reduce recurrence. This study explored the link between triptan properties and treatment outcomes.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Clinical Neurology

Background:

  • Triptans are crucial for migraine treatment, with efficacy potentially linked to central nervous system (CNS) penetration.
  • Lipophilicity, a measure of drug solubility in fats, influences how easily a drug crosses cell membranes, including the blood-brain barrier.

Purpose of the Study:

  • To investigate the correlation between the lipophilicity of oral triptans and their clinical efficacy and tolerability.
  • To determine if increased lipophilicity enhances therapeutic outcomes or influences adverse event profiles.

Main Methods:

  • A meta-analysis of existing data on oral triptans was performed.
  • Lipophilicity coefficients (logD at pH 7.4) were correlated with efficacy parameters (response, pain-free rates) and tolerability (adverse events, recurrence).

Related Experiment Videos

Main Results:

  • No significant correlation was found between triptan lipophilicity and efficacy variables like response or pain-free rates.
  • A trend suggested a correlation between higher lipophilicity and increased central nervous system (CNS) adverse events (AE).
  • A weak negative correlation indicated that higher lipophilicity might be associated with a reduced recurrence rate.

Conclusions:

  • Lipophilicity is not a critical factor for improving the efficacy of triptans in migraine treatment.
  • Increased lipophilicity in triptans is associated with a higher incidence of CNS adverse events.
  • The physico-chemical property of lipophilicity may play a role in reducing migraine recurrence.